Skip to main content
Loading...
Menu top
Help
User account menu
Log in
Main navigation
Programme
Posters
Industry Symposia
Membership
Mobile Application
Menu
Login
Close
Main navigation mobile
Programme
Posters
Industry Symposia
Membership
Mobile Application
Back
20 résultats
Grid
List
The role of PD-L1 and TILsCD8+ in oral cavity and pharyngeal cancers treated with definitive radiation
Head and neck re-irradiation: retrospective single institution study of 60 patients treated with curative intention.
Head and Neck Re-Irradiation: Toxicity Analysis and Correlation between Toxicity and Dosimetric Parametres
survival outcome of chemotherapy and radiotherapy in patients with metastatic tonsillar cancer(M1)
Dosimetric evaluation of dysphagia in early stage larynx cancer treated with definitive radiotherapy
Onco-biota as prognostic factors in Head and Neck Squamous Cell Carcinoma
“A Retrospective study comparing sequential boost versus integrated boost using volumetric Arc Radiotherapy along with concurrent chemotherapy for Locally Advanced Head and Neck Cancer”.
Point Of Care Ultrasound (POCUS) in Tracheostomy in Head and Neck Cancer : A Prospective Study.
Proton arc therapy: advantages over conventional proton therapy and impact on range uncertainties
Omitting postoperative contralateral radiotherapy in head and neck cancers. A single center report.
Hypofractionated re-irradiation with Cyberknife for locoregionally recurrent head and neck cancer: a single-center study.
Evolution of phase 1 clinical trials for head and neck cancer patients based on the experience of a dedicated phase I Unit.
A novel approach for improving the quality and deliverability of VMAT plans in head and neck cancer
Long term outcomes of the FiGaRO trial: 18F-FDG-PET in Guided Dose-Painting with Intensity Modulated Radiotherapy in Oropharyngeal Tumours
Induction radiochemotherapy with low dose fractionation XRT in patients with advanced HNSCC.
Evaluation and implementation of open face masks with surface-guided radiotherapy (SGRT)
treatment tolerance and toxicity in elderly nasopharyngeal cancer patients and implication on outcomes
Regional Experience of Cemiplimab, in Locally advanced and stage IV Head and Neck Cutaneous Squamous Cell Carcinomas
Survival outcomes of elderly patients treated with a curatively-intended treatment for HPV-related oropharyngeal cancer: a multicenter cohort study
hypofractionated radiotherapy in elderly/frail head and neck cancer patients: our experience from COVID-19 pandemic.